Company / Current Liabilities per Share
Inmune Bio, Inc. Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.38
FY2025
5-year range
$0.32 / $1.03
FY2021-FY2025
Trend
-6.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $1.03 to $0.38 over the past 2 years.
Based on SEC 10-K filings.
0.38 in FY2025 with a 5-year CAGR of +18.0%.
Improved from $1.03 to $0.38 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -14.9%
- 5-Year CAGR
- +18.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 6.1% year-over-year.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 49.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.38 | -6.1% |
| FY2024 | $0.40 | -60.9% |
| FY2023 | $1.03 | +68.2% |
| FY2022 | $0.61 | +89.2% |
| FY2021 | $0.32 | +96.1% |
| FY2020 | $0.16 | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026